Metraipolis › archive › dc_a32fd59cf06f

USP39 at the crossroads of cancer immunity: regulating immune evasion and immunotherapy response through RNA splicing and ubiquitin signaling — Europe PMC PMID:40990019

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40990019
DOI
10.3389/fimmu.2025.1665775
License (as archived)
solo-consultazione
Archived
2026-11-10T01:52:25.642Z
SHA-256 of the archived text
f5b55973d66161c670a3a918c6ad3a1f2ea8ee82accde56582c5bba8fca2ed97
Stable URL of this page
https://metraipolis.com/documento/dc_a32fd59cf06f

How to cite

USP39 at the crossroads of cancer immunity: regulating immune evasion and immunotherapy response through RNA splicing and ubiquitin signaling — Europe PMC PMID:40990019 — Europe PMC (en), https://europepmc.org/article/MED/40990019 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a32fd59cf06f (Metraipolis archive dc_a32fd59cf06f, sha256 f5b55973d66161c670a3a918c6ad3a1f2ea8ee82accde56582c5bba8fca2ed97)
BibTeX
@misc{dca32fd59cf06f,
  title = {USP39 at the crossroads of cancer immunity: regulating immune evasion and immunotherapy response through RNA splicing and ubiquitin signaling — Europe PMC PMID:40990019},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40990019},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a32fd59cf06f; sha256 f5b55973d66161c670a3a918c6ad3a1f2ea8ee82accde56582c5bba8fca2ed97},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40990019. Agents can read the archived copy with the MCP tool read_document.